|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07C 229/24 | (2006.01) |
| C07C 229/24 | (2013.01) | ||
| C07C 233/36 | (2006.01) | ||
| C07C 233/36 | (2013.01) | ||
| C07C 233/47 | (2006.01) | ||
| C07C 233/47 | (2013.01) | ||
| C07C 237/06 | (2006.01) | ||
| C07C 237/06 | (2013.01) | ||
| C07C 237/08 | (2006.01) | ||
| C07C 237/08 | (2013.01) | ||
| A61K 31/164 | (2006.01) | ||
| A61K 31/165 | (2006.01) |
| (11) | Number of the document | 3668834 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18780258.2 |
| Date of filing the European patent application | 2018-08-17 | |
| (97) | Date of publication of the European application | 2020-06-24 |
| (45) | Date of publication and mention of the grant of the patent | 2024-10-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/000284 |
| Date | 2018-08-17 |
| (87) | Number | WO 2019/036000 |
| Date | 2019-02-21 |
| (30) | Number | Date | Country code |
| 201762546887 P | 2017-08-17 | US |
| (72) |
DU, Xinyao , CA
|
| (73) |
Acuitas Therapeutics, Inc. ,
6190 Agronomy Road Suite 402
University of British Columbia - KETR, Vancouver, British Columbia V6T 1W5,
CA
|
| (54) | LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS |
| LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS |